Sidley Austin represented Vera Therapeutics, Inc. in the transaction. Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here